Straumann Holding AG Cash on Hand 2012-2021 | SAUHY

Straumann Holding AG cash on hand from 2012 to 2021. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Straumann Holding AG cash on hand for the quarter ending December 31, 2021 was $0.966B, a 237.68% increase year-over-year.
  • Straumann Holding AG cash on hand for 2021 was $0.966B, a 43.17% increase from 2020.
  • Straumann Holding AG cash on hand for 2020 was $0.675B, a 156.02% increase from 2019.
  • Straumann Holding AG cash on hand for 2019 was $0.264B, a 7.87% decline from 2018.
Straumann Holding AG Annual Cash on Hand
(Millions of US $)
2021 $966
2020 $675
2019 $264
2018 $286
2017 $289
2016 $168
2015 $332
2014 $506
2013 $416
2012 $150
2011 $428
Straumann Holding AG Quarterly Cash on Hand
(Millions of US $)
2021-12-31 $966
2020-12-31 $675
2020-06-30 $395
2019-12-31 $264
2018-12-31 $286
2017-12-31 $289
2017-06-30 $143
2016-12-31 $168
2016-06-30 $315
2015-12-31 $332
2014-12-31 $506
2013-12-31 $416
2013-06-30 $344
2012-12-31 $150
2012-06-30 $126
2011-12-31 $428
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.137B $2.685B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
West Pharmaceutical Services (WST) United States $24.592B 50.23
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09